Our Mission

The United Nation's Millennium Development Goals cites the reduction of neonatal mortality as one of the most pressing issues for 2015 and beyond. Over 10 million children below the age of five die each year, and 40% of these deaths occur within the first 28 days, known as the neonatal period.

That's 4 million babies

dying every year.

That's a hard pill to swallow, and it's one we're not comfortable ignoring. That's why NeoTech Global is determined to design an FDA Class 1 or 2 medical device for neonatal care. We want this device to be a quality product, and that means it must be designed with careful consideration for its stakeholders, manufacturers, and users; deliberately constructed with the goal in mind; prototyped based on rigorous engineering theories that have been successfully reduced to concept; and manufactured using high-caliber materials from trusted suppliers. That's quality.

The map above shows the global distribution of infant mortalities from 2010-2014. Infant mortality rate is the metric displayed, and it is defined as the number of infants, per 1,000 births, that die before reaching the age of one. It's clear to see that these rates are highest in the developing world - namely, Central America and Africa. That's why the mission of NeoTech Global is

to develop affordable, quality

medical technologies for infants

everywhere.